-
1
-
2دورية أكاديمية
الإتاحة: https://doi.org/10.1016/j.ejca.2024.114153Test
https://pure.eur.nl/en/publications/75adb13f-7de3-40c2-994e-822da7df2829Test
https://pure.eur.nl/ws/files/153652316/Quality_of_life_gains_in_frail_and_intermediate-fit_patients_with_multiple_Myeloma.pdfTest
http://www.scopus.com/inward/record.url?scp=85195564473&partnerID=8YFLogxKTest -
3
-
4دورية أكاديمية
الإتاحة: https://doi.org/10.1016/j.eclinm.2023.102194Test
https://pure.eur.nl/en/publications/4623efa4-7212-4534-9348-be57ca8ce949Test
https://pure.eur.nl/ws/files/104523973/The_risk_of_recurrent_venous_thromboembolism_after_discontinuation_of_anticoagulant_therapy_in_patients_with_cancer-associated_thrombosis.pdfTest
http://www.scopus.com/inward/record.url?scp=85170408116&partnerID=8YFLogxKTest -
5دورية أكاديمية
الإتاحة: https://doi.org/10.1016/j.eclinm.2023.102167Test
https://pure.eur.nl/en/publications/e1fd1f4b-ec57-4d80-8a6c-9985fab3e904Test
https://pure.eur.nl/ws/files/115631517/Ixazomib_daratumumab_and_low-dose_dexamethasone_in_intermediate-fit_patients_with_newly_diagnosed_multiple_myeloma_an_open-label_phase_2_trial.pdfTest
http://www.scopus.com/inward/record.url?scp=85169037609&partnerID=8YFLogxKTest -
6
-
7
-
8دورية أكاديمية
-
9
-
10